Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl fumarate for diffuse traumatic brain injury
IRCT20240610062071N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) and Diffuse axonal injury (DAI) comparing Dimethyl fumarate with Placebo (2 arms). Primary endpoints: Glasgow Coma Scale, Glasgow Outcome Scale and 4 more. Started May 2026; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
traumatic brain injury (TBI)Diffuse axonal injury (DAI)
Beyond the preview
Go deeper on IRCT20240610062071N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240610062071N1.